Physician
Infectious Disease
Dr. Alexander Velazquez, MD
Alexander Velazquez works in the field of Infectious Disease. He attended Ross University School of Medicine. Alexander Velazquez, MD is a published doctor and has 1 publication published. The lastest was: 'The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections.' Alexander Velazquez accepts Medicare.
Publications
Schools
Ross University School Of MedicineDominica West Indies
Ponce School Of MedicinePonce Puerto Rico
Orlando Regional HealthcareOrlando Fl
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Orlando Health
-
Ross University School of Medicine
Hospital
-
Central Florida Regional Hospital
Drug Facts
NPI NUMBER |
|
1912153057 |
NPPES Provider LastName |
|
VELAZQUEZ |
NPPES Provider FirstName |
|
ALEXANDER |
NPPES Provider ZIPCode |
|
327017853 |
NPPES Provider State |
|
FL |
Specialty Description |
|
Internal Medicine |
Total Claim Count |
|
343.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1912153057 |
Last Name Of The Provider |
VELAZQUEZ |
First Name Of The Provider |
ALEXANDER |
View All |
|
Similar Doctors
|
Dr. Harrinarine Madhosingh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Godson I. Oguchi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anibal J. Maldonado, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Fernando S. Alvarado, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Naveed S. Hamid, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Timothy Cooper, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher Cooper, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Carlos J. Ruiz, MD
|
|
Dr. Javier E. Marinez, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Javier E. Marinez, MD
|
Doctor Directory | TOS | twitter | FB | Angel | blog